Table 1.

Molecular characteristics of immunoglobulin (Ig) receptors derived from Epstein-Barr virus–negative AIDS-related lymphoma (ARL)

Case Histology IgH (Homology) IgL (Homology)
ARL-3  DLCL  VH7.4.1/IgM (96.6%) Vκ1-A20 (97.5%)  
ARL-4  SNCL VH3-15/IgG (84.5%)  Vκ4 (89.4%)  
ARL-7 SNCL  VH3-15/IgM (93.7%)  Vκ1-26 (98.2%) 
ARL-8  DLCL  VH1-8/IgM (87.1%) Vκ1 (88.8%)  
ARL-10  SNCL VH3-13/IgM (85.7%)  Vκ3-41 (86.0%)  
ARL-14 SNCL  VH4-34/IgM (94.8%) Vκ4 (97.5%) 
Case Histology IgH (Homology) IgL (Homology)
ARL-3  DLCL  VH7.4.1/IgM (96.6%) Vκ1-A20 (97.5%)  
ARL-4  SNCL VH3-15/IgG (84.5%)  Vκ4 (89.4%)  
ARL-7 SNCL  VH3-15/IgM (93.7%)  Vκ1-26 (98.2%) 
ARL-8  DLCL  VH1-8/IgM (87.1%) Vκ1 (88.8%)  
ARL-10  SNCL VH3-13/IgM (85.7%)  Vκ3-41 (86.0%)  
ARL-14 SNCL  VH4-34/IgM (94.8%) Vκ4 (97.5%) 

DLCL indicates diffuse large cell lymphoma; SNCL, small noncleaved lymphoma; ARL, AIDS-related lymphoma.

Close Modal

or Create an Account

Close Modal
Close Modal